Back to search
FDAFDA · Food and drugs·Recall number D-1173-2019

Prostaglandin Tri-Mix 20:30:1, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

Published April 24, 2019 · Recall initiated: April 2, 2019

Summary

FDA records drug Class II recall D-1173-2019, published April 24, 2019 and initiated April 2, 2019. Recalling firm: Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy; Status: Terminated; Reported quantity: 58 vials; Lot: All Lots. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of sterility assurance.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy
Distributor
Nationwide
Lot
All Lots
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Prostaglandin Tri-Mix 20:30:1, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN. recalled?

Yes. FDA published recall D-1173-2019 on April 24, 2019. Reported hazard: Lack of sterility assurance.

What should I do if I have this product?

Voluntary: Firm initiated · Letter